Furthermore, IRI is associated with important long-term outcomes including CKD and ESRD and this phase of the natural history of IRI is characterized with interstitial fibrosis and progressive loss of function mediated, in part, by TGF-β and AP-1 mediated gene expression [29,59,60,61]. The gene discussed is FOS; the disease is chronic kidney disease.